Figure S3 from Detection of Promoter DNA Methylation in Urine and Plasma Aids the Detection of Non–Small Cell Lung Cancer
Bin Liu(College of Marin), Alicia Hulbert(Johns Hopkins University), Cassandra Villani(University of Illinois Chicago), Robert A. Winn(Virginia Commonwealth University), Christian Ascoli(University of Illinois Chicago), James G. Herman(UPMC Hillman Cancer Center), Klara Valyi‐Nagy(University of Illinois Chicago), Αναστασία Κοττόρου(Johns Hopkins University), Apurva Mallisetty(University of Illinois Chicago), Tza‐Huei Wang(Johns Hopkins University), E. Benedetti(University of Illinois Chicago), Julio Ricarte Filho(University of Illinois Chicago), Mary Pasquinelli(University of Illinois Chicago), Ignacio Jusué-Torres(Johns Hopkins University), Tomoaki Ito(Juntendo University Shizuoka Hospital), Lawrence Feldman(University of Illinois Chicago), Ron C. Gaba(University of Illinois Chicago), Chen Chen(Central South University), Malek G. Massad(University of Illinois Chicago), Odile David(Tulane University), Malcolm V. Brock(Johns Hopkins University), Kyla Holmes(University of Illinois Chicago), Nicole Gastala(University of Illinois Chicago), Kristen Rodgers(Johns Hopkins University)
Cited by 0
Related Papers
Inactivation of the DNA-Repair Gene<i>MGMT</i>and the Clinical Response of Gliomas to Alkylating Agents
|New England Journal of Medicine|2000|2.2k
Incidence and functional consequences of <i>hMLH1</i> promoter hypermethylation in colorectal carcinoma
|Proceedings of the National Academy of Sciences|1998|1.9k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k
Isolated Single-Cycle Attosecond Pulses
|Science|2006|1.7k
Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
|Cancer Discovery|2016|909